Canaloplasty and Trabeculotomy with the OMNI System in Patients with Open-Angle Glaucoma: Two-Year Results from the ROMEO Study

5Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Purpose: To provide extended safety and effectiveness follow-up for eyes treated with circumferential canaloplasty and trabeculot-omy (CP+TR) that were included in the 12-month ROMEO study. Setting: Seven multi-subspecialty ophthalmology practices located in 6 states (Arkansas, California, Kansas, Louisiana, Missouri, and New York). Design: Retrospective, multicenter, IRB approved. Subjects: Eligible eyes had mild–moderate glaucoma and were treated with CP+TR with cataract surgery or as a standalone intervention. Methods: Main outcome measures were mean IOP, mean number of ocular hypotensive medications, mean change in number of medications, proportion of patients with a ≥20% reduction in IOP or with IOP ≤18 mmHg, and proportion of patients medication free. Safety outcomes were adverse events and secondary surgical interventions (SSI). Results: Eight surgeons at 7 centers contributed 72 patients stratified by pre-operative intraocular pressure (IOP); >18 mmHg (Grp1), ≤18 mmHg (Grp2). Mean follow-up of 2.1 years (min 1.4, max 3.5). 2-year IOP (SD) was 15.6 mmHg (−6.1 mmHg, −28% from baseline) on 1.4 medications (−0.9, −39%) for Grp1 with cataract surgery; 14.7 mmHg (−7.4 mmHg, −33% from baseline) on 1.6 medications (−0.7, −15%) for Grp1 standalone, 13.7 mmHg (−0.6 mmHg, −4.2%) on 1.2 medications (−0.8, −35%) for Grp2 with cataract surgery, 13.3 mmHg (−2.3 mmHg, −14.7%) on 1.2 medications (−1.0, −46%) for Grp2 standalone. The proportion of patients at 2 years with either a ≥20% IOP reduction or IOP between 6 and 18 mmHg and no increase in medication or SSI was 75% (54 of 72, 95% CI 69.9%, 80.1%). One-third of patients (24 of 72) were medication free whereas 9 of 72 were pre-surgical. No device-related adverse events during extended follow-up; 6 eyes (8.3%) required additional surgical or laser intervention for IOP control after 12 months. Conclusion: CP+TR provides effective IOP control that is sustained for 2 years or more.

Cite

CITATION STYLE

APA

Williamson, B. K., Vold, S. D., Campbell, A., Hirsch, L., Selvadurai, D., Aminlari, A. E., … Dickersonjr, J. E. (2023). Canaloplasty and Trabeculotomy with the OMNI System in Patients with Open-Angle Glaucoma: Two-Year Results from the ROMEO Study. Clinical Ophthalmology, 17, 1057–1066. https://doi.org/10.2147/OPTH.S407918

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free